Shield is a derisked commercial stage, pharmaceutical company focused on addressing iron deficiency in adults with or without anaemia. Shield therapeutics plc is focused on the development and commercialization of latestage, hospitalfocused pharmaceuticals. Trading signals for shield therapeutics plc with buy, sell, hold recommendations, technical analysis, and trading strategy. We pride ourselves on providing solutions to unmet medical needs and delivering value to our shareholders. Services include clinical development, regulatory strategy, product strategy, due diligence. We utilise our biological expertise and our powerful computerbased platform to create and analyse network models of disease processes, identifying patterns of proteins that could be disrupted to treat disease. James has served on shields board of directors for almost 3 years as a. Shield therapeutics is a pharmaceutical company developing and commercializing latestage, mineralderived pharmaceuticals. There are currently 5 active directors and 1 active secretary according to the latest confirmation statement submitted on 2nd september 2019. Its lead asset, feraccru accrufer in the states, is. Shield therapeutics plc, today provides an update and clarification relating to the aegish2h clinical trial, the data from which was primarily designed to be used 8 jan 2020 shield therapeutics announces exclusive licence agreement with beijing aosaikang pharmaceutical co. This unique area or candle chart enables you to clearly notice the movements of this shield therapeutics share within the last hours of trading, as well as providing you with key data such as the daily change, high and low prices. Shield therapeutics has had a hard time of it, their main drug turned down by the fda.
Amilia stone 28th january 2020 shield therapeutics lon. Shield therapeutics plc good demand for feraccru in europe. Shield therapeutics plc is a specialty pharmaceutical company focused on the development and commercialization of latestage, hospitalfocused pharmaceuticals. Shield has a rare opportunity to build an integrated, highly profitable specialty pharma business. Read all the latest shield therapeutics plc stx ordinary shares 1. Stx is a commercialstage company delivering specialty products that address patients unmet medical needs, with an initial focus on treating iron deficiency id with ferric maltol. Shield therapeutics plc is a specialty pharmaceutical company focused on the development and commercialization of secondary carefocused pharmaceuticals. Ownership structure of a company has been found to affect share performance over time. Shield therapeutics plc, announces an update on legal proceedings with teva pharmaceutical industries ltd teva.
It engages in the development and commercialization of secondary care focused pharmaceuticals. Shield therapeutics is an independent specialty pharmaceutical company focused on the development and commercialisation of latestage, mineralderived hospital pharmaceuticals which address areas of high unmet medical need. Stx, a commercial stage, pharmaceutical company with a focus on addressing iron deficiency with its lead product feraccru accrufer ferric maltol, a novel oral iron treatment, announces that, following discussions with major shareholders and with mutual agreement, carl sterritt has informed the company of his decision to resign from the. Shield therapeutics plc update on legal proceedings. Sterritt had left following discussions with major shareholders and with mutual agreement, the company said. Shield therapeutics plc encouraged by us interest in iron. Shield therapeutics plc free company information from companies house including registered office address, filing history, accounts, annual.
Shield s feraccru likely to command high market share and branded pricing capital network analyst emma ulker assesses recent progress made at shield therapeutics plc lon. Sell everything, short market, make money and then renter likes. Stx, a specialty pharmaceutical company focused on secondary care, today announces its unaudited interim results for the six months ended 30 june 2017. Weybridge, surrey, united kingdom industries biotechnology, pharmaceutical, therapeutics founded date 2008 founders carl sterritt, christian schweiger operating status active funding status ipo last funding type series a. Shield therapeutics plc expects to sign more outlicence agreements in the coming months for feraccru its flagship iron deficiency treatment the. Shield therapeutics plc major extension to approval in. Shield therapeutics plc annual balance sheet for stx. Uk shield therapeutics plc annual balance sheet wsj.
The drugs approved and marketed in europe, with a us approval decision pending for july 27. Shield therapeutics plc officers free information from. Shield therapeutics plc filing history free information. Shields feraccru likely to command high market share and branded pricing capital network analyst emma ulker assesses recent progress made at shield therapeutics plc lon. Shield is a derisked commercial stage, pharmaceutical company delivering innovative specialty pharmaceuticals to address patients. Shield therapeutics stx has announced a technical update to findings.
The latest shield therapeutics plc stx ordinary shares 1. Profile shield therapeutics more shield therapeutics plc is a pharmaceutical company. The latest earnings release shield therapeutics plcs aim. Shield therapeutics stock price today markets insider. Shield therapeutics company profile office locations. Shield therapeutics is a truly innovative and entrepreneurial specialty pharmaceutical company, always seeking to provide solutions to unmet medical needs. Shield therapeutics plc interim report for the six months. Shield therapeutics next step a us partnering deal. See insights on shield therapeutics including office locations, competitors, revenue, financials. Stx, a commercial stage, pharmaceutical company with an initial focus on addressing iron deficiency, is pleased to announce the appointment of james karis as nonexecutive chairman of the company with immediate effect. Jan 23, 2019 about shield therapeutics plc shield is a commercial stage, pharmaceutical company delivering innovative specialty pharmaceuticals to address patients unmet medical needs. Iron deficiency focused shield therapeutics said founder and chief executive carl sterritt had resigned with immediate effect. About shield therapeutics plc shield therapeutics plc is a specialty pharmaceutical company focused on the development and commercialization of secondary carefocused pharmaceuticals.
Shield therapeutics plc has increased its earnings per share eps by an average of 36% a year, over the last three years using a line of best fit. Its lead product is feraccru, a novel therapy for the treatment of iron deficiency anemia in patients with inflammatory bowel disease. Reason for the notification please mark the appropriate box or boxes with an x an acquisition or disposal of voting rights. Ln shield therapeutics plc stock traders cheat sheet. Shield therapeutics plc targeting more lucrative feraccru. Shield is well positioned to become a fast growing, independent, international specialty pharmaceutical company due to the strength of its products and team, and with great thanks to all of our supportive shareholders.
Dow jones, a news corp company news corp is a network of leading companies in. Shield therapeutics plc interim report 2017 4 in the period since our preliminary results announcement, shield has continued to make progress targeting feraccru at ida patients with ibd in the uk and germany, whilst also successfully augmenting our balance sheet through the warrant exercise and placing in june. Stx, a commercial stage, pharmaceutical company delivering innovative specialty pharmaceuticals to address patients unmet medical needs, today provides a business and unaudited trading update for the year ended 31 december 2018. Our clear purpose is to help our patients become people again, by enabling them to enjoy the things that make the difference in their everyday lives. I am going to take a deep dive into shield therapeutics plcs most recent ownership structure, not a frequent subject of discussion among individual investors. The companys product, feraccru, is an oral treatment for iron deficiency anemia ida in patients for whom intravenous iron or blood transfusions is needed.
Access our live advanced streaming chart forshield therapeutics plc share, free of charge. It engages in the development and commercialization of secondary care. Shield therapeutics plc, a specialty pharmaceutical company, in the development and commercialization of hospitalfocused pharmaceuticals to treat unmet medical needs. Stx, a commercial stage, pharmaceutical company with an initial focus on addressing iron deficiency, announces its preliminary group results for the year ended 31 december 2018. Shield therapeutics plc is a pharmaceutical company. Management and board of directors shield therapeutics. Stx, a commercial stage, pharmaceutical company with a focus on addressing iron deficiency with or without anaemia via its lead product feraccru, announces that the swiss agency for therapeutic products swissmedic has approved a major extension of the approved indication for feraccru to now include treatment of all adults with iron deficiency id with or.
Please indicate if the issuer is a nonuk issuer please mark with an x if appropriate nonuk issuer. Shield therapeutics plc free company information from companies house including registered office address, filing history, accounts, annual return, officers, charges, business activity. Shield therapeutics plc incorporated in england and wales with company no. About data services data coverage data management digital solutions ondemand apis software indexes newswires ag solutions. Shield therapeutics plc agrees deal in china for feraccru. Shield therapeutics plcs iss governance qualityscore as of na is na. Shield therapeutics plc is an active company incorporated on 3 september 2015 with the registered office located in gateshead, tyne and wear. Shield therapeutics turns the corner, tipped as a buy. Shield therapeutics plc has a 4 week average price of 81. L stock quote, history, news and other vital information to help you with your stock trading and investing. Shield therapeutics is a specialty pharmaceutical company focused on the development and commercialisation of late.
Financial news articles for shield therapeutics plc ord 1. Global pharmabiotech services company, full product development preclinical through to marketing. An acquisition or disposal of financial instruments. Who are the major shareholders in shield therapeutics plc. Shield therapeutics feraccru pharmaceutical company. View recent trades and share price information for shield therapeutics plc stx ordinary shares 1. Shield therapeutics plc interim report for the six months ended 30 june 2017 london, uk, 20 september 2017. Shield therapeutics plc has been running for 4 years. This decision has now been reversed, and it looks like theyve turned the corner into near future positive. Stx announced in june 2017 signalled that losses became smaller relative to the prrior years level as a result of recent tailwinds today i want to provide a brief commentary on how market analysts perceive shield therapeuticss earnings growth outlook over the next couple of years and whether the future. Stx, a specialty pharmaceutical company focused on secondary care, is pleased to provide a progress update on the initial stages of the launch of feraccru, our recently approved, welltolerated oral iron product for the treatment of iron deficiency anaemia ida, in. L stock quote, history, news and other vital information to help you with your stock trading and.
Shield therapeutics plc was founded in 2008 and is based in gateshead, the united kingdom. Shield therapeutics is a wellfunded, high potential, commercial stage specialtypharma company. This unique area or candle chart enables you to clearly notice the movements of this shield therapeutics. Shield therapeutics ceo and founder carl sterritt resigns. See who you know at shield therapeutics plc, leverage your professional network, and get hired. Its lead asset, feraccru, is an oral treatment for. Shield therapeutics plc shield therapeutics plc is a specialty pharmaceutical company focused on the development and commercialization of secondary carefocused pharmaceuticals. Dow jones, a news corp company news corp is a network of leading companies in the worlds of diversified media, news. About shield therapeutics specialty pharmaceutical company. About shield therapeutics plc shield is a commercial stage, pharmaceutical company delivering innovative specialty pharmaceuticals to address patients unmet medical needs.
1488 1420 1198 1160 269 900 1048 1242 1164 244 424 848 1424 1375 717 553 1018 194 1310 1329 1163 1149 951 299 1153 1123 1209 566 1399 1409 1277 1335 967 1235 1033